『Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency』のカバーアート

Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

著者： Annenberg Center for Health Sciences
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder that causes accumulation of sphingomyelin in various organs. In addition to a low incidence, ASMD has a heterogeneous presentation that makes management challenging. Join experts Margaret McGovern, MD, PhD, and Pramod Mistry, MD, PhD, in this review of the diagnosis and treatment of patients with ASMD.Annenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

    Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials
    2022/05/26
    • Overview of olipudase alfa
    • Efficacy and safety of olipudase alfa from phase 2 and 3 trials
    続きを読む 一部表示
    27 分
  • Clinical Management and Treatment Monitoring Part 2

    Clinical Management and Treatment Monitoring Part 2
    2022/05/26
    • Surveillance recommendations for patients with ASMD
    • Ongoing symptomatic management and support
    • Role of liver transplantation
    続きを読む 一部表示
    11 分
  • Clinical Management and Treatment Monitoring Part 1

    Clinical Management and Treatment Monitoring Part 1
    2022/05/26
    • Initial evaluation and management of ASMD
    • Clinical trial enrollment
    続きを読む 一部表示
    4 分
adbl_web_anon_alc_button_suppression_c
まだレビューはありません